SB
Spearhead Bio, Inc.
SEC filingOther Technology · Saint Louis, MO
Amount raised$1.2Msold at filing
Total offering$1.8M$550K still open
Investors in the raise4count reported to the SEC
FiledJun 23, 2026first sale Jun 18, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Keith SlotkinExecutive Officer, Director
Harold DaviesExecutive Officer, Director
Michael BielskiExecutive Officer, Director
Thomas LauritaDirector
Executive officers, directors and promoters as listed on the Form D.